The global market for neuroprotective agents was valued at $REDACTED billion in 2016 and $REDACTED billion. in 2017
The scope of this report covers the global market for small molecule drugs, monoclonal antibodies, gene and cell therapies, and other biotechnology products that are approved or being developed for the treatment of neurological disorders. 更多
